Jun 24, 2022 04:39 PM (GMT+8) · EqualOcean
Jiuzhou pharmaceutical announced that recently, the company received the "simplified equity change report" from the information disclosure obligor Zhongbei group and its concerted actors Taizhou Goethe, Luo Yuefang, Hua Lirong, linhuilu and helimin. This equity change was mainly due to the passive decline in the shareholding ratio of the controlling shareholder Zhejiang Zhongbei Jiuzhou Group Co., Ltd. (hereinafter referred to as "Zhongbei group") and its persons acting in concert as a result of the company's non-public issuance of a shares in 2020, and the reduction in the shareholding ratio of the controlling shareholder and its persons acting in concert as a result, the shareholding ratio of the company held by the controlling shareholder and its persons acting in concert decreased by 4.9940%, which did not touch the tender offer. After this equity change, the proportion of shares held by the controlling shareholders and those acting in concert will be reduced from 52.2769% to 47.2829%.